Search

Search Constraints

You searched for: Author/Creator Mathieu, S

Search Results

4. SAT0117 Retention rates of adalimumab, etanercept, and infliximab as 1st- or 2nd-line biotherapy for rheumatoid arthritis patients in daily practice in auvergne. (15th June 2017)

5. AB0696 Retention rates of adalimumab, etanercept, and infliximab as first- or second-line biotherapies for spondyloarthritis patients in daily practice in auvergne (france). (15th June 2017)